Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – In patients with vestibular schwannomas related to neurofibromatosis type 2 (NF2), gamma knife radiosurgery can achieve good tumor control in about two-thirds of…
NEW YORK (Reuters Health) – The results of a randomized trial indicate that sequential and alternating chemotherapy with radiotherapy provide similar survival and larynx preservation in patients with…
NEW YORK (Reuters Health) – The addition of cetuximab to a fluoropyrimideine-based chemotherapy regimen reduces progression-free survival and worsens quality of life in patients with metastatic colorectal cancer,…
NEW YORK (Reuters Health) – While qualitative immunochemical fecal occult blood tests (FOBTs) may offer advantages over traditional guaiac-based FOBTs for colorectal cancer screening, there are large differences…
NEW YORK (Reuters Health) – Physicians at The University of Texas M. D. Anderson Cancer Center have identified several characteristics of unilateral malignant breast tumors that are associated…
DMC Neurosurgeon Sandeep Mittal uses EEG and brain surgery to decode the secrets of adult epilepsy – Part I of a two-part series. ~ Detroit Medical Center Sandeep…
A place all their own, where every doctor is a pediatrician and specialists hold their hands. Children’s Hospital of Michigan — where everything we do is just for…
Doctors at Detroit Medical Center are treating prostate cancer with cryoablation, an innovative procedure that freezes cancer cells and preserves surrounding tissue. Patients usually return home the same…
NEW YORK (Reuters Health) – A single nucleotide polymorphism in the tumor suppressor TP53 gene appears to be a risk factor for glioblastoma multiforme at an earlier age…
By Will Boggs, MD NEW YORK (Reuters Health) – Pretreatment with dacarbazine, a DNA alkylating agent, enhances vaccine-induced antitumor immunity in patients with melanoma, according to a report…
